HGEN insider filings

HUMANIGEN, INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-20. Screen HGEN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for HGEN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — HUMANIGEN, INC

FiledFormInsiderReported transactionsSource
2023-10-204Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL LP — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Cheval Holdings, Ltd. — 10% owner
Sale (S): 34,253 @ $0.01 · Sale (S): 75,887 @ $0.01 · Sale (S): 276,210 @ $0.01EDGAR
2022-07-294Hohneker John — DirectorGrant/award (A): 63,195 (derivative) @ $0EDGAR
2022-07-294Kilcoyne Adrian — Chief Medical OfficerGrant/award (A): 537,164 (derivative) @ $0EDGAR
2022-07-294Buxton Cheryl — DirectorGrant/award (A): 78,362 (derivative) @ $0EDGAR
2022-07-294Chappell Dale — Chief Scientific Officer, Director, 10% ownerGrant/award (A): 518,205 (derivative) @ $0EDGAR
2022-07-294Boehm Rainer J. — DirectorGrant/award (A): 73,307 (derivative) @ $0EDGAR
2022-07-294Jordan Edward P. — Chief Commercial OfficerGrant/award (A): 455,010 (derivative) @ $0EDGAR
2022-07-294Xie Yili Kevin — DirectorGrant/award (A): 83,418 (derivative) @ $0EDGAR
2022-07-294Durrant Cameron — Chief Executive Officer, DirectorGrant/award (A): 808,906 (derivative) @ $0EDGAR
2022-07-294BARLIANT RONALD — DirectorGrant/award (A): 55,612 (derivative) @ $0EDGAR
2022-07-294MORRIS TIMOTHY E — COO and CFOGrant/award (A): 600,360 (derivative) @ $0EDGAR
2022-05-204Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
Cheval Holdings, Ltd. — 10% owner
Purchase (P): 17,370 @ $1.96 · Purchase (P): 34,740 @ $1.96 · Purchase (P): 121,590 @ $1.96 · Purchase (P): 32,381 @ $2.19 · Purchase (P): 64,762 @ $2.19 · Purchase (P): 226,665 @ $2.19 · +3 moreEDGAR
2022-03-154Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Cheval Holdings, Ltd. — 10% owner
Purchase (P): 100,000 @ $3 · Purchase (P): 200,000 @ $3 · Purchase (P): 700,000 @ $3EDGAR
2022-03-144Kilcoyne Adrian — Chief Medical OfficerPurchase (P): 7,000 @ $2.53 · Purchase (P): 5,000 @ $2.78EDGAR
2022-03-104Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
Cheval Holdings, Ltd. — 10% owner
Purchase (P): 238 (derivative) @ $1.20 · Purchase (P): 5 (derivative) @ $1.20 · Purchase (P): 147 (derivative) @ $0.79 · Purchase (P): 79 (derivative) @ $0.75 · Purchase (P): 476 (derivative) @ $1.20 · Purchase (P): 10 (derivative) @ $1.20 · +6 moreEDGAR
2022-03-044Durrant Cameron — Chief Executive Officer, DirectorPurchase (P): 40,000 @ $2.34EDGAR
2022-03-044Jordan Edward P. — Chief Commercial OfficerPurchase (P): 12,500 @ $2.32EDGAR
2022-03-044Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
Cheval Holdings, Ltd. — 10% owner
Purchase (P): 680 (derivative) @ $0.60 · Purchase (P): 11 (derivative) @ $0.33 · Purchase (P): 5 (derivative) @ $0.70 · Purchase (P): 173 (derivative) @ $0.35 · Purchase (P): 127 (derivative) @ $0.90 · Purchase (P): 1,360 (derivative) @ $0.60 · +9 moreEDGAR
2022-01-144Durrant Cameron — Chief Executive Officer, DirectorGrant/award (A): 84,385 (derivative) @ $0EDGAR
2022-01-144Chappell Dale — Chief Scientific Officer, Director, 10% ownerGrant/award (A): 36,550 (derivative) @ $0EDGAR
2022-01-144Jordan Edward P. — Chief Commercial OfficerGrant/award (A): 43,763 (derivative) @ $0EDGAR
2022-01-144Kilcoyne Adrian — Chief Medical OfficerGrant/award (A): 38,411 (derivative) @ $0EDGAR
2022-01-144MORRIS TIMOTHY E — COO and CFOGrant/award (A): 59,841 (derivative) @ $0EDGAR
2022-01-044Hohneker John — DirectorGrant/award (A): 3,538 (derivative) @ $2.84EDGAR
2022-01-044Xie Yili Kevin — DirectorGrant/award (A): 4,674 (derivative) @ $2.84EDGAR
2022-01-044Buxton Cheryl — DirectorGrant/award (A): 5,523 (derivative) @ $2.84EDGAR
2022-01-044Boehm Rainer J. — DirectorGrant/award (A): 5,117 (derivative) @ $2.84EDGAR
2022-01-044Jordan Edward P. — Chief Commercial OfficerGrant/award (A): 29,400 (derivative) @ $0EDGAR
2022-01-044Chappell Dale — Chief Scientific Officer, Director, 10% ownerGrant/award (A): 44,600 (derivative) @ $0EDGAR
2022-01-044Kilcoyne Adrian — Chief Medical OfficerGrant/award (A): 34,500 (derivative) @ $0EDGAR
2022-01-044Durrant Cameron — Chief Executive Officer, DirectorGrant/award (A): 76,000 (derivative) @ $0EDGAR
2022-01-044BARLIANT RONALD — DirectorGrant/award (A): 4,163 (derivative) @ $2.84EDGAR
2022-01-044MORRIS TIMOTHY E — COO and CFOGrant/award (A): 51,000 (derivative) @ $0EDGAR
2021-11-264Kilcoyne Adrian — Chief Medical OfficerDisposition to issuer (D): 5,863 (derivative) @ $4.53EDGAR
2021-11-264Jordan Edward P. — Chief Commercial OfficerDisposition to issuer (D): 4,966 (derivative) @ $4.53EDGAR
2021-11-264Durrant Cameron — Chief Executive Officer, DirectorDisposition to issuer (D): 17,660 (derivative) @ $4.53EDGAR
2021-10-204Xie Yili Kevin — DirectorGrant/award (A): 42,866 (derivative) @ $0EDGAR
2021-10-204Hohneker John — DirectorGrant/award (A): 42,866 (derivative) @ $0EDGAR
2021-10-044Chappell Dale — Chief Scientific Officer, Director, 10% ownerGrant/award (A): 22,626 (derivative) @ $0EDGAR
2021-10-044Durrant Cameron — Chief Executive Officer, DirectorGrant/award (A): 17,660 (derivative) @ $0EDGAR
2021-10-044Jordan Edward P. — Chief Commercial OfficerGrant/award (A): 4,966 (derivative) @ $0EDGAR
2021-10-044Kilcoyne Adrian — Chief Medical OfficerGrant/award (A): 5,863 (derivative) @ $0EDGAR
2021-08-134Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Cheval Holdings, Ltd. — 10% owner
Sale (S): 8,224 @ $17.07 · Sale (S): 4,316 @ $17.16 · Sale (S): 21,929 @ $17.07 · Sale (S): 11,510 @ $17.16 · Sale (S): 79,494 @ $17.07 · Sale (S): 41,725 @ $17.16EDGAR
2021-07-304Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Cheval Holdings, Ltd. — 10% owner
Sale (S): 727 @ $17.04 · Sale (S): 2,204 @ $17.03 · Sale (S): 1,938 @ $17.04 · Sale (S): 5,879 @ $17.03 · Sale (S): 7,027 @ $17.04 · Sale (S): 21,311 @ $17.03EDGAR
2021-07-234Chappell Dale — Chief Scientific Officer, Director, 10% owner
Cheval Holdings, Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Sale (S): 9,957 @ $17.14 · Sale (S): 13,350 @ $17.04 · Sale (S): 419 @ $17.04 · Sale (S): 26,553 @ $17.14 · Sale (S): 35,601 @ $17.04 · Sale (S): 1,117 @ $17.04 · +3 moreEDGAR
2021-07-164Chappell Dale — Chief Scientific Officer, Director, 10% owner
Cheval Holdings, Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Sale (S): 1,138 @ $17.06 · Sale (S): 3,036 @ $17.06 · Sale (S): 11,003 @ $17.06EDGAR
2021-07-094Chappell Dale — Chief Scientific Officer, Director, 10% owner
Cheval Holdings, Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Sale (S): 3,601 @ $17.17 · Sale (S): 22,203 @ $17.37 · Sale (S): 9,602 @ $17.17 · Sale (S): 59,207 @ $17.37 · Sale (S): 34,807 @ $17.17 · Sale (S): 214,626 @ $17.37EDGAR
2021-07-024Chappell Dale — Chief Scientific Officer, Director, 10% owner
Cheval Holdings, Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Sale (S): 16,444 @ $17.28 · Sale (S): 10,575 @ $17.10 · Sale (S): 7,714 @ $17.12 · Sale (S): 43,851 @ $17.28 · Sale (S): 28,198 @ $17.10 · Sale (S): 20,569 @ $17.12 · +3 moreEDGAR
2021-06-254Chappell Dale — Chief Scientific Officer, Director, 10% owner
Cheval Holdings, Ltd. — 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Sale (S): 9,985 @ $18.28 · Sale (S): 10,465 @ $18.37 · Sale (S): 75,000 @ $17.80 · Sale (S): 26,625 @ $18.28 · Sale (S): 27,906 @ $18.37 · Sale (S): 200,000 @ $17.80 · +3 moreEDGAR
2021-06-214Chappell Dale — Chief Scientific Officer, Director, 10% owner
BLACK HORSE CAPITAL MANAGEMENT LLC — 10% owner
BLACK HORSE CAPITAL LP — 10% owner
Black Horse Capital Master Fund Ltd. — 10% owner
Cheval Holdings, Ltd. — 10% owner
Sale (S): 12,730 @ $19.50 · Sale (S): 13,607 @ $19.17 · Sale (S): 30,186 @ $18.50 · Sale (S): 34,431 @ $19.40 · Sale (S): 36,284 @ $19.17 · Sale (S): 80,496 @ $18.50 · +3 moreEDGAR

Recent 8-K events — HUMANIGEN, INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-01-088-K1.01 — Entry into a Material Definitive Agreement
1.03 — Bankruptcy or Receivership
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-258-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-04-198-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-04-068-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-138-K7.01 — Regulation FD DisclosureEDGAR
2023-03-028-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-228-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs